Vaccine Limits Herpes Zoster Infections Following Stem Cell Transplant – OncLive
OncLive |
Vaccine Limits Herpes Zoster Infections Following Stem Cell Transplant
OncLive blood cells Treatment with an inactivated varicella zoster virus vaccine, known as V212, lowered the cumulative incidence rate of herpes zoster (HZ) infection and HZ-related complications for patients undergoing autologous stem cell transplantation … |
